Technical Analysis for RCEL - Avita Medical Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 19.89 | -0.10% | -0.02 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical RCEL trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -0.10% | |
| Bollinger Band Squeeze | Range Contraction | -0.10% | |
| NR7 | Range Contraction | -0.10% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible NR7 | about 15 hours ago |
| Possible Inside Day | about 15 hours ago |
| Possible Pocket Pivot | 1 day ago |
| Possible NR7 | 1 day ago |
| Down 1% | 2 days ago |
Get a Trading Assistant
- Earnings date: ???
Avita Medical Limited Description
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Rare Diseases Clinical Research Wound Suspension Dermatology Regenerative Medicine Injuries Platform Technology Burns Aesthetics Genodermatoses Treatment Solutions Epidermolysis Bullosa Skin Chronic Wound Chronic Wounds
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 153.55 |
| 52 Week Low | 16.87 |
| Average Volume | 179,933 |
| 200-Day Moving Average | 23.03 |
| 50-Day Moving Average | 21.98 |
| 20-Day Moving Average | 20.45 |
| 10-Day Moving Average | 20.49 |
| Average True Range | 0.71 |
| ADX | 16.32 |
| +DI | 20.71 |
| -DI | 31.93 |
| Chandelier Exit (Long, 3 ATRs ) | 20.14 |
| Chandelier Exit (Short, 3 ATRs ) | 21.26 |
| Upper Bollinger Band | 21.54 |
| Lower Bollinger Band | 19.36 |
| Percent B (%b) | 0.24 |
| BandWidth | 10.65 |
| MACD Line | -0.47 |
| MACD Signal Line | -0.48 |
| MACD Histogram | 0.0057 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.24 | ||||
| Resistance 3 (R3) | 20.23 | 20.12 | 20.18 | ||
| Resistance 2 (R2) | 20.12 | 20.03 | 20.12 | 20.16 | |
| Resistance 1 (R1) | 20.00 | 19.97 | 20.06 | 20.01 | 20.14 |
| Pivot Point | 19.89 | 19.89 | 19.92 | 19.89 | 19.89 |
| Support 1 (S1) | 19.77 | 19.80 | 19.83 | 19.78 | 19.64 |
| Support 2 (S2) | 19.66 | 19.74 | 19.66 | 19.62 | |
| Support 3 (S3) | 19.54 | 19.66 | 19.60 | ||
| Support 4 (S4) | 19.55 |
